Committee for Orphan Medicinal Products (COMP): 7-8 February 2012
Date: 07/02/2012 to 08/02/2012
Location: European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases. It does not currently publish the minutes or agendas of its meetings. It does publish a meeting report after each meeting.